France health minister says EU will fight price of Gilead’s Sovaldi

Eric Palmer
Resistance to the that Gilead Sciences has put on , a drug that will cure millions of hepatitis C, is reaching a fever pitch. Now 14 European countries are banding together to press Gilead for deep discounts, saying that without them they will have to ration care.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS